Queensland Health Fact sheet: Long-acting injections of buprenorphine for opioid dependence treatment

Queensland Health Fact sheet: Long-acting injections of buprenorphine for opioid dependence treatment

  • Filetype

    PDF

  • Last updated

    26 March 2020

  • Filesize

    224.59kb

Download

cart

0

Long-acting injectable formulations of buprenorphine (LAI-BPN) are becoming available in Queensland for the treatment of opioid dependence under the provisions of the Queensland Opioid Treatment Program (QOTP). This factsheet outlines the current regulatory status for Buvidal® and Sublocade® in Queensland.